FI971397A0 - Sykliset haksapeptidit, joilla on antibioottinen aktiivisuus - Google Patents

Sykliset haksapeptidit, joilla on antibioottinen aktiivisuus

Info

Publication number
FI971397A0
FI971397A0 FI971397A FI971397A FI971397A0 FI 971397 A0 FI971397 A0 FI 971397A0 FI 971397 A FI971397 A FI 971397A FI 971397 A FI971397 A FI 971397A FI 971397 A0 FI971397 A0 FI 971397A0
Authority
FI
Finland
Prior art keywords
cyclic hexapeptides
antibiotic antiviral
antiviral
antibiotic
hexapeptides
Prior art date
Application number
FI971397A
Other languages
English (en)
Swedish (sv)
Other versions
FI971397A (fi
FI119988B (fi
Inventor
Hidenori Ohki
Masaki Tomishima
Akira Yamada
Hisashi Takasugi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI971397(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI971397A0 publication Critical patent/FI971397A0/fi
Publication of FI971397A publication Critical patent/FI971397A/fi
Application granted granted Critical
Publication of FI119988B publication Critical patent/FI119988B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI971397A 1994-10-07 1997-04-04 Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus FI119988B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9420425 1994-10-07
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GB9508745 1995-04-28
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound
JP9501983 1995-09-29
PCT/JP1995/001983 WO1996011210A1 (en) 1994-10-07 1995-09-29 Cyclic hexapeptides having antibiotic activity

Publications (3)

Publication Number Publication Date
FI971397A0 true FI971397A0 (fi) 1997-04-04
FI971397A FI971397A (fi) 1997-05-27
FI119988B FI119988B (fi) 2009-05-29

Family

ID=26305774

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971397A FI119988B (fi) 1994-10-07 1997-04-04 Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus

Country Status (27)

Country Link
US (2) US6107458A (fi)
EP (1) EP0788511B1 (fi)
JP (2) JP2897427B2 (fi)
KR (1) KR100353303B1 (fi)
CN (1) CN1203089C (fi)
AR (1) AR041770A1 (fi)
AT (1) ATE229541T1 (fi)
AU (1) AU696949B2 (fi)
BR (2) BRPI9504791B8 (fi)
CA (1) CA2202058C (fi)
DE (2) DE122008000025I2 (fi)
DK (1) DK0788511T3 (fi)
ES (1) ES2187575T3 (fi)
FI (1) FI119988B (fi)
FR (1) FR08C0028I2 (fi)
HK (1) HK1004136A1 (fi)
HU (1) HU228151B1 (fi)
IL (1) IL115484A (fi)
LU (1) LU91452I2 (fi)
MX (1) MX9702531A (fi)
NL (1) NL300352I2 (fi)
NO (2) NO328483B1 (fi)
OA (1) OA10475A (fi)
PT (1) PT788511E (fi)
RU (1) RU2165423C2 (fi)
TR (1) TR199501229A2 (fi)
WO (1) WO1996011210A1 (fi)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
WO1998057923A1 (fr) * 1997-06-18 1998-12-23 Fujisawa Pharmaceutical Co., Ltd. Nouveau procede de preparation
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
US6232290B1 (en) * 1998-02-09 2001-05-15 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides with antimicrobial activity
CA2360220C (en) * 1999-02-11 2009-09-08 Emisphere Technologies, Inc. Oxadiazole compounds and compositions for delivering active agents
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) * 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
DE60040989D1 (de) 1999-07-27 2009-01-15 Aventis Pharma Gmbh Cyclohexapeptide, deren herstellung und verwendung in pharmazeutische zusammensetzungen
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) * 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
ATE452637T1 (de) 2001-01-29 2010-01-15 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
JP4784093B2 (ja) * 2002-08-08 2011-09-28 アステラス製薬株式会社 イソオキサゾリル安息香酸の製造法
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
EP1654036B1 (en) 2003-07-22 2007-12-26 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
CA2537574A1 (en) * 2003-09-05 2005-03-24 Merck & Co., Inc. Stationary phases and a purification process using the stationary phases
CN1902177A (zh) * 2003-09-22 2007-01-24 万有制药株式会社 新哌啶衍生物
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
CN101198598A (zh) * 2004-05-20 2008-06-11 弗尔德里克斯制药股份有限公司 2-((杂)芳基)-苯并噁唑化合物及其衍生物、组合物以及用于稳定和抑制甲状腺素转运蛋白错重叠的方法
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
BRPI0515483A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
JP5043668B2 (ja) 2004-09-20 2012-10-10 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体および治療薬としてのそれらの使用
JP5149009B2 (ja) 2004-09-20 2013-02-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体
TW200626154A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
MX2007003327A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
CA2583177A1 (en) * 2004-10-13 2006-04-27 Ptc Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
MX2007015216A (es) 2005-06-03 2008-02-22 Xenon Pharmaceuticals Inc Derivados de aminotiazol y sus usos como agentes terapeuticos.
CN101282936B (zh) * 2005-10-07 2012-05-16 橘生药品工业株式会社 氮化杂环化合物及包含其的药物组合物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
HUE027022T2 (en) 2007-08-13 2016-08-29 Monsanto Technology Llc Preparations and procedures for controlling nematodes
KR20100075892A (ko) * 2007-10-29 2010-07-05 아스테라스 세이야쿠 가부시키가이샤 폴리펩티드 화합물
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
AU2009271328B2 (en) * 2008-06-24 2012-09-06 Irm Llc Compounds and methods for modulating G protein-coupled receptors
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
SI2699327T1 (sl) 2011-04-20 2015-11-30 Xelia Pharmaceuticals Aps Postopek čiščenja mikafungina
CN102775476B (zh) 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
EP2709609B1 (en) 2011-05-17 2017-10-04 Shionogi & Co., Ltd. Heterocyclic compounds
KR20140069097A (ko) * 2011-09-09 2014-06-09 산도즈 아게 미카펀진 중간체의 제조
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
EP3150623B1 (en) * 2014-05-29 2019-04-03 Shanghai Techwell Biopharmaceutical Co., Ltd Solvate of cyclic peptide compound, preparation method for same, and uses thereof
EP3226885A4 (en) * 2014-10-07 2018-07-18 Alaparthi, Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN108752430B (zh) * 2018-05-31 2022-02-18 杭州中美华东制药有限公司 米卡芬净钠新晶型及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ｐｔｐ－１ｂ阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI912873A (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
CZ288974B6 (cs) * 1992-03-19 2001-10-17 Eli Lilly And Company Acylový derivát echinocandinu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a jeho pouľití

Also Published As

Publication number Publication date
CA2202058A1 (en) 1996-04-18
ES2187575T3 (es) 2003-06-16
MX9702531A (es) 1997-06-28
BR9504791A (pt) 1996-10-22
TR199501229A2 (tr) 1996-07-21
LU91452I2 (fr) 2008-08-04
HUT77736A (hu) 1998-07-28
NO971544L (no) 1997-06-04
PT788511E (pt) 2003-04-30
BR9504791B1 (pt) 2010-10-05
EP0788511B1 (en) 2002-12-11
DK0788511T3 (da) 2003-03-31
KR100353303B1 (ko) 2003-01-15
JPH10507174A (ja) 1998-07-14
DE69529172T2 (de) 2003-04-17
IL115484A0 (en) 1996-01-19
JP3518665B2 (ja) 2004-04-12
DE122008000025I2 (de) 2011-02-17
NL300352I1 (nl) 2008-08-01
BRPI9504791B8 (pt) 2019-12-31
JPH10324695A (ja) 1998-12-08
NO971544D0 (no) 1997-04-04
NO328483B1 (no) 2010-03-01
FR08C0028I2 (fi) 2009-11-20
OA10475A (en) 2002-04-08
ATE229541T1 (de) 2002-12-15
JP2897427B2 (ja) 1999-05-31
AR041770A1 (es) 2005-06-01
CN1203089C (zh) 2005-05-25
US6107458A (en) 2000-08-22
WO1996011210A1 (en) 1996-04-18
EP0788511A1 (en) 1997-08-13
US6265536B1 (en) 2001-07-24
NO2010016I2 (no) 2011-10-17
IL115484A (en) 2000-07-16
HU228151B1 (en) 2012-12-28
DE122008000025I1 (de) 2008-08-21
NL300352I2 (nl) 2008-11-03
CN1168675A (zh) 1997-12-24
FR08C0028I1 (fi) 2008-08-15
DE69529172D1 (de) 2003-01-23
RU2165423C2 (ru) 2001-04-20
KR970707150A (ko) 1997-12-01
HK1004136A1 (en) 1998-11-20
NO2010016I1 (no) 2010-08-16
FI971397A (fi) 1997-05-27
AU696949B2 (en) 1998-09-24
FI119988B (fi) 2009-05-29
CA2202058C (en) 2007-11-06
AU3578095A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
FI971397A (fi) Sykliset haksapeptidit, joilla on antibioottinen aktiivisuus
DE69519322D1 (de) Greifer
DE59407422D1 (de) Gerippestruktur
FI964468A (fi) Adenosiinijohdannaisia
DK0731078T3 (da) Terpenquinon med antitumoraktivitet
NO934805D0 (no) Manifoldanordning
KR950018692U (ko) 배기 기능을 갖는 깔때기
KR960010870A (ko) 항생제의 제조방법
NO930865L (no) Tunglöftkran-arrangement
FI934032A0 (fi) Dubbelviraformer med flexibla draeneringslister
DE69326536D1 (de) Antitumor Impfstoff
KR940021030U (ko) 공기 배출기
BR7300444U (pt) Disposicao em balao de ar
FI940841A0 (fi) Lockoeppnare foer konservburk med undertryck
LV10926A (lv) Preparats ar imunmodulejosam ipasibam
KR950000369U (ko) 진공배기장치의 연결구
KR950018727U (ko) 가루가 묻지 않는 파스텔
KR950015090U (ko) 화살의 오늬구조
KR940019615U (ko) 화살의 구조
KR950001113U (ko) 자전거용 에어클랙숀
DK133192D0 (da) Biofilter
LV10450A (lv) O-heteroaril- O-alkilheteroaril- O-alkenilheteroaril- un O-alkinilheteroaril- makrolidi
FI932020A0 (fi) Baot foersedd med fjaedrande upphaengda skidor eller pontoner
KR970000444U (ko) 뇨량계가 부설된 체스트 보틀
KR960036341U (ko) 뇨량계가 부설된 체스트 보틀

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ASTELLAS PHARMA INC.

Free format text: ASTELLAS PHARMA INC.

FG Patent granted

Ref document number: 119988

Country of ref document: FI

SPCF Supplementary protection certificate application filed

Free format text: SPC C20090038

Spc suppl protection certif: C20090038

SPCG Supplementary protection certificate granted

Spc suppl protection certif: 369

Extension date: 20200929

MA Patent expired